NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Obesity & Diabetes Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Obesity & Diabetes Week

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Insulin Resistance



 Caenorhabditis elegans model of insulin resistance developed



October 17th, 2005

Researchers have developed a Caenorhabditis elegans model of insulin resistance.

According to a study from the United States, "O-linked N-acetylglucosamine (O-GlcNAc) is an evolutionarily conserved modification of nuclear pore proteins, signaling kinases, and transcription factors. The O-GlcNAc transferase (OGT) catalyzing O-GlcNAc addition is essential in mammals and mediates the last step in a nutrient-sensing 'hexosamine-signaling pathway.' This pathway may be deregulated in diabetes and neurodegenerative disease."

"To examine the function of O-GlcNAc in a genetically amenable organism, we describe a putative null allele of OGT in...


Source: Obesity & Diabetes Week (2005-10-17)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login